ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,585Medicare Part D Prescriptions Filled, Including Refills

Rank: 67 out of 278

$585K Total Retail Price of All Prescriptions

Rank: 82 out of 278

236 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 236 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 236 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 8,663 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
FUROSEMIDE 346 302 1 6
HYDROCODONE-ACETAMINOPHEN 325 272 S3 2 1
OMEPRAZOLE 311 248 3 3
LISINOPRIL 290 241 4 5
LEVOTHYROXINE SODIUM 284 228 5 2
AMLODIPINE BESYLATE 280 261 6 7
POTASSIUM CHLORIDE 244 237 7 17
METOPROLOL TARTRATE 215 180 8 9
SIMVASTATIN 203 171 9 4
ATORVASTATIN CALCIUM 202 149 10 13
METFORMIN HCL 195 165 11 8
HYDROCHLOROTHIAZIDE 190 168 12 15
GABAPENTIN 170 153 13 12
POLYETHYLENE GLYCOL 3350 148 132 14 74
WARFARIN SODIUM 144 132 15 11
MIRTAZAPINE 136 128 16 61
LANTUS 132 89 17 56
DIGOXIN 129 121 18 40
NOVOLOG 128 80 19 122
TRAMADOL HCL 127 109 20 22
ALBUTEROL SULFATE 116 110 21 141
DONEPEZIL HCL 114 114 22 29
CYMBALTA 112 81 23 41
HYDROCODONE BIT-IBUPROFEN 109 85 S3 24 239
RANITIDINE HCL 105 95 25 27
NAMENDA 104 104 26 48
SERTRALINE HCL 104 87 26 25
ATENOLOL 92 69 28 18
GLIPIZIDE 92 67 28 55
TAMSULOSIN HCL 86 72 30 32
OXYCODONE-ACETAMINOPHEN 85 80 S2 31 71
ISOSORBIDE MONONITRATE ER 84 80 32 33
CITALOPRAM HBR 78 78 33 21
QUETIAPINE FUMARATE 75 75 34 80
KLOR-CON M20 75 65 34 42
LEVEMIR 74 62 36 183
TRIAMTERENE-HCTZ 73 60 37 58
FLUTICASONE PROPIONATE 68 45 38 44
NEXIUM 63 29 39 14
ACETAMINOPHEN-CODEINE 63 59 S3 39 144
CARVEDILOL 62 50 41 23
CRESTOR 61 44 42 19
BUSPIRONE HCL 58 54 43 178
ENALAPRIL MALEATE 57 57 44 70
PROPRANOLOL HCL 57 45 44 132
ESCITALOPRAM OXALATE 55 55 46 63
DIVALPROEX SODIUM 55 20 46 103
AZITHROMYCIN 53 43 48 39
NITROFURANTOIN 52 50 49 278
CLOPIDOGREL 51 45 50 20
GLYBURIDE 51 40 R 50 88
RANEXA 50 50 52 213
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.